Nuclear ubiquitin ligases, NF-κB degradation, and the control of inflammation

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Transcriptional control of the vast majority of genes involved in the inflammatory response requires the nuclear factor κB (NF-κB) family of transcription factors. Stimulation and termination of NF-κB activity are subject to stringent spatiotemporal control. According to the classical model of NF-κB regulation, both activation and termination mechanisms are centered on inhibitor of NF-κB (IκB) proteins. Whereas activation of NF-κB requires degradation of the I?Bs, the main mechanism respon- sible for termination of NF-κB activity is the resynthesis of a specific IκB, IκBα, which sequesters NF-κB dimers in the nucleus and translocates them to the cyto- plasm in an inactive form. Studies now show that an additional mechanism that is required to prevent the uncontrolled activity of NF-κB proteins is their nuclear degradation. At least two E3 ubiquitin ligases, one of which seems to be essential for control of nuclear NF-κB p65 (also known as RelA) in myeloid cells, have been identified. Moreover, additional evidence indicates that individual NF-κB dimers with particular activating or repressive properties may be differentially controlled by nuclear degradation, thus paving the way for the exploitation of NF-κB degradation pathways for therapeutic purposes.

Original languageEnglish
Article number11pe1
JournalScience Signaling
Volume1
Issue number1
DOIs
Publication statusPublished - Jan 8 2008

Fingerprint

Ligases
Ubiquitin
Inflammation
Degradation
Ubiquitin-Protein Ligases
Myeloid Cells
Dimers
Cytoplasm
Proteins
Transcription Factors
Chemical activation
Genes
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology
  • Medicine(all)

Cite this

Nuclear ubiquitin ligases, NF-κB degradation, and the control of inflammation. / Natoli, Gioacchino; Chiocca, Susanna.

In: Science Signaling, Vol. 1, No. 1, 11pe1, 08.01.2008.

Research output: Contribution to journalArticle

@article{b038a00439ba4ba4ab461d3114b88609,
title = "Nuclear ubiquitin ligases, NF-κB degradation, and the control of inflammation",
abstract = "Transcriptional control of the vast majority of genes involved in the inflammatory response requires the nuclear factor κB (NF-κB) family of transcription factors. Stimulation and termination of NF-κB activity are subject to stringent spatiotemporal control. According to the classical model of NF-κB regulation, both activation and termination mechanisms are centered on inhibitor of NF-κB (IκB) proteins. Whereas activation of NF-κB requires degradation of the I?Bs, the main mechanism respon- sible for termination of NF-κB activity is the resynthesis of a specific IκB, IκBα, which sequesters NF-κB dimers in the nucleus and translocates them to the cyto- plasm in an inactive form. Studies now show that an additional mechanism that is required to prevent the uncontrolled activity of NF-κB proteins is their nuclear degradation. At least two E3 ubiquitin ligases, one of which seems to be essential for control of nuclear NF-κB p65 (also known as RelA) in myeloid cells, have been identified. Moreover, additional evidence indicates that individual NF-κB dimers with particular activating or repressive properties may be differentially controlled by nuclear degradation, thus paving the way for the exploitation of NF-κB degradation pathways for therapeutic purposes.",
author = "Gioacchino Natoli and Susanna Chiocca",
year = "2008",
month = "1",
day = "8",
doi = "10.1126/stke.11pe1",
language = "English",
volume = "1",
journal = "Science Signaling",
issn = "1937-9145",
publisher = "American Association for the Advancement of Science",
number = "1",

}

TY - JOUR

T1 - Nuclear ubiquitin ligases, NF-κB degradation, and the control of inflammation

AU - Natoli, Gioacchino

AU - Chiocca, Susanna

PY - 2008/1/8

Y1 - 2008/1/8

N2 - Transcriptional control of the vast majority of genes involved in the inflammatory response requires the nuclear factor κB (NF-κB) family of transcription factors. Stimulation and termination of NF-κB activity are subject to stringent spatiotemporal control. According to the classical model of NF-κB regulation, both activation and termination mechanisms are centered on inhibitor of NF-κB (IκB) proteins. Whereas activation of NF-κB requires degradation of the I?Bs, the main mechanism respon- sible for termination of NF-κB activity is the resynthesis of a specific IκB, IκBα, which sequesters NF-κB dimers in the nucleus and translocates them to the cyto- plasm in an inactive form. Studies now show that an additional mechanism that is required to prevent the uncontrolled activity of NF-κB proteins is their nuclear degradation. At least two E3 ubiquitin ligases, one of which seems to be essential for control of nuclear NF-κB p65 (also known as RelA) in myeloid cells, have been identified. Moreover, additional evidence indicates that individual NF-κB dimers with particular activating or repressive properties may be differentially controlled by nuclear degradation, thus paving the way for the exploitation of NF-κB degradation pathways for therapeutic purposes.

AB - Transcriptional control of the vast majority of genes involved in the inflammatory response requires the nuclear factor κB (NF-κB) family of transcription factors. Stimulation and termination of NF-κB activity are subject to stringent spatiotemporal control. According to the classical model of NF-κB regulation, both activation and termination mechanisms are centered on inhibitor of NF-κB (IκB) proteins. Whereas activation of NF-κB requires degradation of the I?Bs, the main mechanism respon- sible for termination of NF-κB activity is the resynthesis of a specific IκB, IκBα, which sequesters NF-κB dimers in the nucleus and translocates them to the cyto- plasm in an inactive form. Studies now show that an additional mechanism that is required to prevent the uncontrolled activity of NF-κB proteins is their nuclear degradation. At least two E3 ubiquitin ligases, one of which seems to be essential for control of nuclear NF-κB p65 (also known as RelA) in myeloid cells, have been identified. Moreover, additional evidence indicates that individual NF-κB dimers with particular activating or repressive properties may be differentially controlled by nuclear degradation, thus paving the way for the exploitation of NF-κB degradation pathways for therapeutic purposes.

UR - http://www.scopus.com/inward/record.url?scp=45149090556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45149090556&partnerID=8YFLogxK

U2 - 10.1126/stke.11pe1

DO - 10.1126/stke.11pe1

M3 - Article

VL - 1

JO - Science Signaling

JF - Science Signaling

SN - 1937-9145

IS - 1

M1 - 11pe1

ER -